期刊文献+

沉默HIF-1α基因逆转结肠癌MDR的研究

Research on silencing HIF-1α gene reversing MDR in colon cancer
下载PDF
导出
摘要 目的探讨沉默HIF-1α基因对结肠癌多药耐药(MDR)逆转的影响。方法建立MDR1、HIF-1α的慢病毒和亲本HT-29细胞多细胞球的体系,低氧引导形成耐药的模型,分为Neg-miR感染组(A组)、亲本HT-29 MCS未处理(常氧)组(B组)、MDR1 miR感染组(C组)、亲本HT-29 MCS未处理(低氧)组(D组)、HIF-1αmiR感染组(E组),检测耐药扭转情况和肿瘤细胞死亡情况。结果 MDR1与HIF-1α的两套miR的重组慢病毒的干扰体系可以跟随细胞进行传代,能够显著对靶基因蛋白表达产生抑制作用;各组细胞周期比较,D组、E组和C组、B组对比差异均有统计学意义(P<0.05),E组与B组对比差异有统计学意义(P<0.05),C组与E组对比差异有统计学意义(P<0.05);各组敏感性和细胞凋亡率比较,D组(VCR、ADR、5-Fu)、C组(5-Fu)、E组(5-Fu)与B组对比差异有统计学意义(P<0.05),E组(VCR、ADR、5-Fu)、C组(ADR、VCR)与D组对比差异有统计学意义(P<0.05),C组(5-Fu)与E组对比差异有统计学意义(P<0.05)。结论沉默HIF-1α能够显著逆转HT-29MCS细胞对5-Fu、VCR和ADR的耐药性。 Objective To explore the effect of silencing HIF-1αgene for reversing MDR of colon cancer.Methods The slow virus of MDR1,HIF-1αand the multicellular spheroids system of the parental HT-29 cell were established.The drug resistance model was formed by the low-oxygen guide.They were divided into five groups,including Neg-miR infection group(group A),parent N group(group B),MDR1-miR infection group(group C),parent H group(group D)and HIF-1αmiR infection group(group E).Then the drug resistance reversion and tumor cell death were detected.Results The interference system of two sets of miR recombinant lentivirus with MDR1 and HIF-1 could be passaged by following cells,could significantly produce the inhibiting effect on the expression of the target gene protein(P<0.05);in the cell cycle:there was statistically significant difference between the group D and group E and between group C and group B(P<0.05).There was statistically significant difference between the group E and group B(P<0.05).There was statistically significant difference between the group C and group E(P<0.05).The sensitivity and apoptosis rate in each group:there was statistically significant difference among group D(VCR,ADR,5-Fu),group C(5-Fu),group E(5-Fu)and group B(P<0.05).There was statistically significant difference between group E(VCR,ADR,5-Fu)and group C(ADR,VCR)with group D(P<0.05).There was statistically significant difference between the group C(5-Fu)and group E(P<0.05).Conclusion Silencing HIF-1αcan significantly reverse the resistance of HT-29 MCS cells to 5-Fu,VCR and ADR.
作者 杨光磊 胡岩芳 张丛 许书清 彭林涛 葛国庆 胡延伟 王钊 张仕东 YANG Guanglei;HU Yanfang;ZHANG Cong;XU Shuqing;PENG Lintao;GE Guoqing;HU Yanwei;WANG Zhao;ZHANG Shidong(Department of General Surgery,Xingtai Municipal People's Hospital,Xingtai,Hebei 054031,China;Department of Neurology,Xingtai Municipal People′s Hospital,Xingtai,Hebei 054031,China)
出处 《重庆医学》 CAS 2018年第26期3372-3374,3378,共4页 Chongqing medicine
基金 河北省邢台市科技计划项目(2017ZC116)
关键词 缺氧诱导因子-1Α 结肠肿瘤 多药耐药 逆转机制 hypoxia-inducible factor-1α colon neoplasms multidrug resistance reversal mechanism
  • 相关文献

参考文献10

二级参考文献126

  • 1张威浩,裘正军,胡志前,孙晶.HIF-1α及多药耐药相关基因在结肠癌中的表达及意义[J].中国癌症杂志,2007,17(11):875-878. 被引量:8
  • 2Semenza GL. Regulation of metabolism by hypoxia-inducible factor 1 [ J]. Cold Spring Harb Syrup Quant Biol,2011,76 :347 -353.
  • 3Ozben T. Mechanisms and strategies to overcome multiple drug re- sistance in cancer [ J ]. Febs Lett, 2006,580 ( 12 ) : 2903 - 2909.
  • 4Buchler P,Reber HA, Buchler MW,et al. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor - 1 and the down-regulation of VEGF gene expression[ J]. Cancer,2004,100( 1 ) :201 - 210.
  • 5Brown JM,Wilson WR. Exploiting tumour hypoxia in cancer treat- ment[J]. Nat Rev Cancer,2004,4(6) :437 -447.
  • 6Semenza GL,Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene en- hancer at a site required for transcriptional activation[ J]. Mol Cell Bio1,1992,12(12) :5447 -5454.
  • 7Ema M ,Taya S,Yokotani N ,et al. A novel bHLH - PAS factor with close sequence similarity to hypoxia-inducible factor 1 alpha regu- lates the VEGF expression and is potentially involved in lung and vascular development [ J ]. Proc Natl Acad Sci USA, 1997,94 ( 9 ) : 4273 - 4278.
  • 8Wiesener MS, Turley H, Allen WE, et al. Induction of endothelial PAS domain protein - 1 by hypoxia: characterization and compari- son with hypoxia-inducible factor - 1 alpha [ J ]. Blood, 1998,92 (7) :2260 -2268.
  • 9Semenza GL. HIF - 1 : mediator of physiological and pathophysio- logical responses to hypoxia [ J]. J Appl Physiol ( 1985 ) , 2000,88 (4) :1474 - 1480.
  • 10Loboda A,Jozkowicz A, Dulak J. HIF - 1 and HIF - 2 transcription factors-similar but not identical [ J ]. Mol Cells ,2010,29 ( 5 ) :435 - 442.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部